Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Stock Market Today (LIVE): Peace Dividend Evaporates as White House Dismisses Iran Proposal and Oil Jumps 4% to Start the Week
09:44am, Monday, 11'th May 2026
Top insights from the latest market news from Monday, May 11, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb
09:29am, Monday, 11'th May 2026
Moderna Inc. (NASDAQ:MRNA) and Novavax Inc. (NASDAQ:NVAX) shares moved higher Monday as traders piled back into vaccine names following renewed concerns over a hantavirus outbreak tied to the MV Hondi
Moderna Shares Surge On Hantavirus Concerns: What Investors Need To Know
09:07am, Monday, 11'th May 2026
Moderna Inc (NASDAQ:MRNA) shares are trading higher during Monday's pre-market session as investors focus shifts to an emerging global health concern, a hantavirus outbreak, that has highlighted the c
Stock Futures Muted After Trump Rejects Iran's Proposal
09:06am, Monday, 11'th May 2026
Stock futures are quietly lower this morning after President Donald Trump rejected Iran's proposal
Hantavirus cases spark surge in pharma and biotech stocks — here's why
07:53am, Monday, 11'th May 2026
Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutions rose in early market trading.
Moderna shares extend gains as hantavirus vaccine work draws attention
07:42am, Monday, 11'th May 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares continued to extend recent gains on Monday as investors welcomed reports that the company is researching a...
Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive.
05:29am, Monday, 11'th May 2026
The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms.
How Hantavirus Made Moderna a Must-Own Stock Again
02:44pm, Friday, 08'th May 2026
The stock has rapidly outpaced the broader market, but the long-term implications of the hantavirus are unclear.
Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know
09:31am, Friday, 08'th May 2026
Moderna Inc (NASDAQ:MRNA) shares are trading higher Friday morning as traders react to peer reviewed Phase 3 flu-vaccine data. Here's what investors need to know.
Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to begin in 2026 CAMBRIDGE, MA / ACCESS Newswire / May 6, 2026 / Moderna, Inc. (NASDAQ:
Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial
05:01pm, Wednesday, 06'th May 2026
Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on Wednesd
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era
10:09am, Monday, 04'th May 2026
Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking.
Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges
02:00am, Saturday, 02'nd May 2026
Revenue: $400 million for Q1 2026, a $300 million increase year-over-year.Net Loss: $1.3 billion on a GAAP basis; $0.5 billion excluding litigation settlement.
Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcript
05:51pm, Friday, 01'st May 2026
Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcript
Stock Market Today, May 1: Tech Stocks Soar on Apple Earnings
12:52pm, Friday, 01'st May 2026
Today, May 1, 2026, Apple's earnings beat extended April's record-setting run for major U.S. benchmarks and spotlighted tech's dominance.
